Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure.
对伊马替尼治疗失败后胃肠道间质瘤患者的舒尼替尼随机、安慰剂对照 III 期试验进行完整的纵向分析
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-11-3005
Demetri George D, Garrett Christopher R, Schöffski Patrick, Shah Manisha H, Verweij Jaap, Leyvraz Serge, Hurwitz Herbert I, Pousa Antonio Lopez, Le Cesne Axel, Goldstein David, Paz-Ares Luis, Blay Jean-Yves, McArthur Grant A, Xu Qiang Casey, Huang Xin, Harmon Charles S, Tassell Vanessa, Cohen Darrel P, Casali Paolo G
